165 results on '"Flamme, Ingo"'
Search Results
2. Chimeric protein probes for C5a receptors through fusion of the anaphylatoxin C5a core region with a small-molecule antagonist
3. Rational design of highly stabilized and selective adrenomedullin analogs
4. Pharmacodynamic effects of molidustat on erythropoiesis in healthy cats.
5. Thrombomucin, a Novel Cell Surface Protein That Defines Thrombocytes and Multipotent Hematopoietic Progenitors
6. Supplementary Figure 1 from PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
7. Supplementary Figure 3 from PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
8. Supplementary Figure Legend from PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
9. Supplementary Figure 4 from PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
10. Data from PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
11. Supplementary Figure 2 from PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
12. Supplementary Figure 5 from PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
13. Supplementary Figures 1-7 from Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
14. Supplementary Materials, Table 1, Figure Legends 1-7 from Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
15. Data from Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
16. The Role of Vascular Endothelial Growth Factors and Their Receptors During Embryonic Vascular Development
17. Vascular Growth in the Extraembryonic Mesoderm of Avian Embryos
18. Success Factors and Obstacles in Academia-Industry Partnerships: A Case Study of a Graduate Program within the Bayer-University of Cologne “Privileged Partnership”
19. Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development
20. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
21. Determination and Modulation of Prolyl‐4‐Hydroxylase Domain Oxygen Sensor Activity
22. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation
23. Genetic evidence for a tumor suppressor role of HIF-2α
24. The impact of N-nitrosomelatonin as nitric oxide donor in cell culture experiments
25. A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity
26. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation
27. Induction of vasculogenesis in quail blastodisc-derived embryoid bodies
28. Cooperative Interaction of Hypoxia-inducible Factor-2α (HIF-2α) and Ets-1 in the Transcriptional Activation of Vascular Endothelial Growth Factor Receptor-2 (Flk-1)
29. Expression and Proteolysis of Vascular Endothelial Growth Factor is Increased in Chronic Wounds
30. Role of SCL/Tal-1, GATA, and Ets transcription factor binding sites for the regulation of Flk-1 expression during murine vascular development
31. Front Cover: Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia (ChemMedChem 10/2018)
32. Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia
33. Identification of Vascular Endothelial Growth Factor (VEGF) Receptor-2 (Flk-1) Promoter/Enhancer Sequences Sufficient for Angioblast and Endothelial Cell-Specific Transcription in Transgenic Mice
34. FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase
35. Design, Synthesis, Enzyme-Inhibitory Activity, and Effect on Human Cancer Cells of a Novel Series of Jumonji Domain-Containing Protein 2 Histone Demethylase Inhibitors
36. Is extraembryonic angiogenesis in the chick embryo controlled by the endoderm?: A morphological study
37. Edge cell migration in the extraembryonic mesoderm of the chick embryo: An experimental and morphological study
38. Prolonged and simplified in vitro culture of explanted chick embryos
39. Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects
40. PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
41. BAY 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I
42. Design, Synthesis, Enzyme-Inhibitory Activity, and Effect on Human Cancer Cells of a Novel Series of Jumonji Domain-Containing Protein 2 Histone Demethylase Inhibitors
43. Prolyl Hydroxylases 2 and 3 Act in Gliomas as Protective Negative Feedback Regulators of Hypoxia-Inducible Factors
44. The impact ofN-nitrosomelatonin as nitric oxide donor in cell culture experiments
45. Nuclear Oxygen Sensing: Induction of Endogenous Prolyl-hydroxylase 2 Activity by Hypoxia and Nitric Oxide
46. Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors
47. mRNA cloning and expression studies of the quail homologue of HIF-2α
48. Up-Regulation of Vascular Endothelial Growth Factor in Stromal Cells of Hemangioblastomas Is Correlated with Up-Regulation of the Transcription Factor HRF/HIF-2α
49. Expression of VEGF in chronic non-healing wounds
50. TheIn VivoActivity of Vascular Endothelial Growth Factor Isoforms in the Avian Embryo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.